117 related articles for article (PubMed ID: 7106669)
1. [Brachycurie therapy of tumors--renaissance of a radio-oncologic method].
Sauer R; Thiel HJ; Müller R
Fortschr Med; 1982 Jun; 100(22):1047-53. PubMed ID: 7106669
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy renaissance.
Goffinet DR; Martinez A; Pooler D; Palos B; Cox R
Front Radiat Ther Oncol; 1980; 15():43-57. PubMed ID: 7239185
[TBL] [Abstract][Full Text] [Related]
3. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
[TBL] [Abstract][Full Text] [Related]
4. [Computer tomographically guided stereotactic interstitial therapy of brain tumors using temporary or permanent 125iodine seed implantation].
Thiel HJ; Huk WJ; Müller R; Sauer R
Rofo; 1983 Mar; 138(3):348-55. PubMed ID: 6403430
[TBL] [Abstract][Full Text] [Related]
5. Multiplanar CT-guided stereotaxis and 125I interstitial radiotherapy. Image-guided tumor volume assessment, planning, dosimetric calculations, stereotactic biopsy and implantation of removable catheters.
Zamorano L; Dujovny M; Malik G; Yakar D; Mehta B
Appl Neurophysiol; 1987; 50(1-6):281-6. PubMed ID: 3329864
[TBL] [Abstract][Full Text] [Related]
6. [Introduction to the use of 125 iodine in interstitial radiotherapy (author's transl)].
Ficari A; De Maio G; Bruni F; Villa P; Breschi R
Radiol Med; 1979 Apr; 65(4):261-6. PubMed ID: 550203
[TBL] [Abstract][Full Text] [Related]
7. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
8. [Interstitial radiotherapy].
Hammer J
Wien Med Wochenschr; 1983 Jun; 133(12):307-9. PubMed ID: 6684364
[TBL] [Abstract][Full Text] [Related]
9. [Physical brachytherapy planning].
Muskalla K
Praxis (Bern 1994); 2001 Sep; 90(36):1532-43. PubMed ID: 11593909
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy and local control.
Sannazzari GL; Ruo Redda MG; Rampino M; Verna R
Rays; 1998; 23(3):427-38. PubMed ID: 9932464
[TBL] [Abstract][Full Text] [Related]
11. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma].
Wang ZM; Wu J; Wang GC; Ren JL; Kjelle D
Ai Zheng; 2002 Oct; 21(10):1145-8. PubMed ID: 12508663
[TBL] [Abstract][Full Text] [Related]
13. [Current status and future perspectives of interstitial 125I seed implantation treatment for malignant tumors].
Cao XF; Lü J
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):81-3. PubMed ID: 22780922
[No Abstract] [Full Text] [Related]
14. [Equipment for rapid and reliable perineal implantation of I-125 seeds in prostatic cancer with reduced radiation exposure].
Bruggmoser G; Nanko N; Hempel M; Heitz R; Wannenmacher M
Strahlenther Onkol; 1987 Sep; 163(9):593-4. PubMed ID: 3660225
[TBL] [Abstract][Full Text] [Related]
15. Radiation exposure after permanent prostate brachytherapy.
Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
[TBL] [Abstract][Full Text] [Related]
16. [Low dose brachytherapy with seeds--an interdisciplinary therapy alternative to radical prostatectomy].
Kahmann F; Henkel T
Praxis (Bern 1994); 2001 Sep; 90(36):1523-31. PubMed ID: 11593908
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
19. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
[TBL] [Abstract][Full Text] [Related]
20. [Brachytherapy in prostatic adenocarcinoma].
Haie-Meder C; Court B; Perrin JL; Wibault P; Lartigau E; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
